Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Sep;91(1089):20180267.
doi: 10.1259/bjr.20180267. Epub 2018 Jun 14.

Obesity, metabolic disease and the pancreas-Quantitative imaging of pancreatic fat

Naomi S Sakai  1 , Stuart A Taylor  1 , Manil D Chouhan  1
Affiliations
Review

Obesity, metabolic disease and the pancreas-Quantitative imaging of pancreatic fat

Naomi S Sakai et al. Br J Radiol. 2018 Sep.

Abstract

The association between pancreatic fat, obesity and metabolic disease is well-documented, and although a potentially exciting target for novel therapies, remains poorly understood. Non-invasive quantitative imaging-derived biomarkers can provide insights into pathophysiology and potentially provide robust trial endpoints for development of new treatments. In this review, we provide an overview of the pathophysiology of non-alcoholic fatty pancreas disease and associations with metabolic factors, obesity and diabetes. We then explore approaches to pancreatic fat quantification using ultrasound, CT and MRI, reviewing the strengths, limitations and current published evidence in the assessment of pancreatic fat. Finally, we explore the broader challenges of pancreatic fat quantification as we move toward translating these methods into the clinical setting.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Pathophysiological mechanisms for non-alcoholic fatty pancreas disease. Intracellular accumulation of lipid is thought to precede the rise in pancreatic tissue adipocytes. Subsequent oxidative stress leads to the release of adipokines and cytokines which trigger an inflammatory response that is ultimately thought to drive beta-cell dysfunction leading to Type 2 diabetes mellitus. MPO, myeloperoxidase; TNF-alpha, tumour necrosis factor-alpha.
Figure 2.
Figure 2.
Complete fatty replacement of the pancreas. Extreme pancreatic steatosis and atrophy – the residual pancreas with presumed borders outlined (dashed white line). The main pancreatic duct is just visible with only minimal lobular tissue.
Figure 3.
Figure 3.
MRS and the differing spectral complexity of pancreatic fat MRS study planning (a) of the liver (i) and pancreas (ii), with corresponding spectra arising from the liver voxel (b) and pancreatic voxel (c). Note differing voxel sizes and the challenge of ensuring inclusion of purely pancreatic tissue within the MRS voxel (a, ii). The water peak is shown in both spectra (b, c) at 4.7 ppm (solid white arrow). Liver fat spectra (b) have been shown to demonstrate six peaks (at 5.3, 4.2, 2.75, 2.1, 1.3 and 0.9 ppm), while pancreatic fat spectra (c) are dominated by single 1.3 ppm methylene peak (clear white arrow). It is not known if this reflects genuine pancreatic fat content or contamination from extra lobular fat. MRS, magnetic resonance spectroscopy.
Figure 4.
Figure 4.
Chemical-shift imaging and pancreatic fat quantification in the presence of fatty infiltration in-phase (a) and out-of-phase (b) CSI in the presence of significant pancreatic fatty infiltration. Note the "india-ink" artefact at fat-water interfaces on out-of-phase images (b), which when combined with in-phase imaging makes quantification in small islands of tissue prone to partial voluming errors. CSI, chemical-shift imaging.
Figure 5.
Figure 5.
Proton density fat fraction imaging images derived from water-only and fat-only are used to generate a parametric fat fraction map across an axial slice. Note low pancreatic intralobular fat fractions (despite fatty infiltration, white-dashed outline). Errors arising from intraluminal (solid black arrows) and peripheral gas (solid white arrows) result in incoherent pixelation.
Figure 6.
Figure 6.
Pancreatic fat segmentation as the pancreas undergoes both fatty infiltration and atrophy, the significance of fat changes (shaded areas) in the intralobular (a), interlobular (b) and extralobular/peripancreatic (c) fat compartments are unknown. Inconsistencies in the way in which these have been reported/evaluated in the literature are a barrier to pooled meta-analyses and robust segmentation methods for quantifying each of these are an important challenge.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Moody A. Health Survey for England 2015: adult overweight and obesity. Leeds, UK: The British Institute of Radiology.; 2016.
    1. OECD. OECD obesity update. 2017. 2018. Available from: http://www.oecd.org/health/obesity-update.htm.
    1. Britton KA, Fox CS. Ectopic fat depots and cardiovascular disease. Circulation 2011; 124: e837–e841. doi: 10.1161/CIRCULATIONAHA.111.077602 - DOI - PubMed
    1. Ogilvie RF. The islands of langerhans in 19 cases of obesity. J Pathol Bacteriol 1933; 37: 473–81. doi: 10.1002/path.1700370314 - DOI
    1. Martínez J, Johnson CD, Sánchez-Payá J, de Madaria E, Robles-Díaz G, Pérez-Mateo M, et al. . Obesity is a definitive risk factor of severity and mortality in acute pancreatitis: an updated meta-analysis. Pancreatology 2006; 6: 206–9. doi: 10.1159/000092104 - DOI - PubMed

MeSH terms